About Us

Founding Chairman, Mr. M. Jawed Akhai comes from a family engaged in the pharmaceutical industry for over five decades Established Martin Dow in 1995 Acquired the pharmaceutical manufacturing facility of Roche Pakistan Ltd. in 2010, along with the acquisition & brand licensing of global top line products Acquired the majority shareholding of Merck Germany in Merck (Pvt) ltd. in 2016 First Pakistani businessman to acquire pharmaceutical and nutraceutical production facilities in France Member of the World Economic Forum Since 2013 Led Martin Dow as the first pharmaceutical from Pakistan to be recognized as a Global Growth Company of the World Economic Forum Passionately active in philanthropy in the Health and Education sectors Besides being the Founding Chairman of Martin Dow, he held many positions with different associations including:

Former Chairman of Pakistan Pharmaceutical Manufacturer’s Association (PPMA)
Member of Karachi Chamber of Commerce & Industry
Member of Pakistan France Business Alliance
Member of Swiss Business Council
Member of Marketing Association of Pakistan


Ali Akhai

After completing his Bachelor of Science business graduate degree (BSc) from Brunel University in the UK, he proceeded to further his education with a double Masters degree.

The first was a Master of Science from University of Hertfordshire, UK in Global Business followed by Master of Science from Novancia Business School, France in International Business Development & Consulting.

In 2016, Ali returned to Pakistan and joined the family business of Martin Dow Group of Companies. He went through a structured orientation program covering Marketing, Finance, Business Development, HR & Regulatory affairs. In 2017, he took on the mantle of Business Development “lead” and launched 8 new products for the Group by mid-2018.

Over the past years at Martin Dow Group, Ali has been trained and groomed by his father and past Founding Chairman Mr. M. Jawed Akhai and has played his part in the leadership team that successfully acquired the majority shareholding of Merck (Pvt) Ltd in 2016.